semaglutide pioneer Efficacy, safety and cardiovascular outcomes of once‐daily oral in patients with type 2 diabetes: The programme - Thethi - 2020 - Diabetes, Obesity and Metabolism Overview of the PIONEER Clinical
Description
As more evidence becomes available on the GLP-1s, expect the halo impact on overlapping comorbidities to accelerate their adoption
Tried Sprout Health
He is one of the most highly regarded experts on treatments for obesity, having done some of the most important research on very low-calorie diets, a variety of medications, bariatric surgery, intervention in primary care settings, and more.
Receive a treatment plan tailored to you
